rs104893787
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000539.3(RHO):c.329G>A(p.Cys110Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C110F) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000539.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHO | NM_000539.3 | c.329G>A | p.Cys110Tyr | missense_variant | 1/5 | ENST00000296271.4 | NP_000530.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHO | ENST00000296271.4 | c.329G>A | p.Cys110Tyr | missense_variant | 1/5 | 1 | NM_000539.3 | ENSP00000296271.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 31, 2020 | Published functional studies demonstrate a damaging effect with disruption of disulfide bonds resulting in severe protein misfolding and inability to bind 11-cis retinal and form mature rhodopsin (Krebs et al., 2010; Behnen et al., 2018); Identified in individuals with autosomal dominant retinitis pigmentosa referred for genetic testing at GeneDx and in published literature (Dryja et al., 1992; Vaithinathan et al., 1994; Milla et al., 1998); Categorized as a Class 2 RHO variant, characterized by misfolding, ER retention, and instability, in published literature (Athanasiou et al., 2018); Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants at the same residue and in nearby residues reported in the Human Gene Mutation Database in individuals with retinitis pigmentosa (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 33576794, 30977563, 29042326, 8088850, 8401533, 9810568, 10051572, 19136713, 30240733, 19913029, 21094163, 16332273, 29773803, 1358680) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2020 | For these reasons, this variant has been classified as Pathogenic. This variant has been reported to affect RHO protein function (PMID: 19913029, 30240733). This variant has been observed to segregate with autosomal dominant retinitis pigmentosa in families (PMID: 8088850, 9810568). ClinVar contains an entry for this variant (Variation ID: 13035). This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with tyrosine at codon 110 of the RHO protein (p.Cys110Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. - |
Retinitis pigmentosa 4 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 15, 1994 | - - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jul 26, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at